Kms Medisurgi Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of KMS Medisurgi Ltd is ₹ 132.8 as of 13 May 15:30 . The P/E Ratio of KMS Medisurgi Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of KMS Medisurgi Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 13.96 crore on March 2025 . This represents a CAGR of -32.93% over 5 years The Dividend Payout of KMS Medisurgi Ltd changed from 13.75 % on March 2021 to 6.6 % on March 2026 . This represents a CAGR of -11.51% over 6 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About KMS Medisurgi Ltd

KMS Medisurgi Limited was incorporated as 'KMS Medisurgi Private Limited' on March 25, 1999 at Mumbai.
The Company converted into a Public Limited Company and name was changed to 'KMS Medisurgi Limited' on June 15, 2016. The Company manufactures & undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive.
It is engaged in the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy Equipments, Blood Banking Equipments and other such Surgical Equipments in India. The Company was established in 1999 as surgical equipment company and since then has been launching new concepts which helped the Indian Healthcare industry.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of KMS Medisurgi Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, KMS Medisurgi Ltd or Vanta Bioscience Ltd?

Market cap of KMS Medisurgi Ltd is 43 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of KMS Medisurgi Ltd and Vanta Bioscience Ltd?

The stock performance of KMS Medisurgi Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KMS Medisurgi Ltd and Vanta Bioscience Ltd?

As of October 25, 2026, the KMS Medisurgi Ltd stock price is INR ₹132.8. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of KMS Medisurgi Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of KMS Medisurgi Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.